pillbase.ru

Pemazyre

Active substance: pemigatinib

pemigatinib

Centralised EU authorisationActive

Marketing holder: Incyte Biosciences Distribution B.V.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 6
  • PEMAZYRE
    TABLET · PEMIGATINIB 9 mg/1
    50881-027
    Incyte Corporation
  • PEMAZYRE
    TABLET · PEMIGATINIB 13.5 mg/1
    50881-028
    Incyte Corporation
  • PEMAZYRE
    TABLET · PEMIGATINIB 4.5 mg/1
    50881-026
    Incyte Corporation
  • PEMIGATINIB
    TABLET · PEMIGATINIB 4.5 mg/1
    70277-501
    Lonza Tampa LLC
  • PEMIGATINIB
    TABLET · PEMIGATINIB 9 mg/1
    70277-502
    Lonza Tampa LLC
All products in this country (6)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-f8d8-7ec9-98fd-5e9c42318be5,01a12091-bb33-7839-a692-cbc66829b810,01a12091-bb3b-71a3-9084-d78030bcc876,01a12096-09d8-79f7-97d5-393244ff2d80,01a1209a-bdfc-7d01-9887-7f86fe9f4de1;count=6 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005266
Registration status
Active
ATC code
L01EN02
Sources
  • product · EMA · EMEA/H/C/005266 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005266 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005266 · Verified 2026-10-09